New Perspective of Antiviral Drugs
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 1434
Special Issue Editor
Interests: medicinal chemistry; antiviral agents; anticancer agents; trypanocidal agents; anti-HBV drugs; anti-HCV drugs; anti-influenza A agents; anti-flavivirus agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
From the beginning of human civilization, viral infections have been part of human life, and still represent one of the greatest burdens for humans and society, with a huge devastating socioeconomic impact. Over the last year, a worst-case scenario of a viral pandemic (i.e., severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has threatened millions of lives, while devastating the primary health care systems across the world. Fortunately, the advancement in the field of antiviral drug discovery over the last forty years led to the development of important therapies that intercept human immunodeficiency virus (HIV) replication or cure hepatitis C virus infections in people suffering from liver disease. Nevertheless, according to the World Health Organization (WHO), we are still a long way from achieving suitable treatments for other viral-infection-related diseases such as SARS, HBV, Influenza, and Ebola. Moreover, the emergence of drug resistance that threatens the efficacy of successful therapies used today and the lack of vaccines for many viral pathogens make the discovery and development of antiviral agents an unmet global need. Urged by this global crisis, the field has been involved in an unprecedented endeavor to enhance established antiviral strategies and develop novel and innovative approaches for new classes of antiviral agents targeting different life cycle pathways that are critical for the virus, including viral and host factors and new antiviral modalities. In the present Special Issue, entitled “New Perspective of Antiviral Drugs”, we are inviting the submission of original research articles, letters, and/or reviews from academia, research institutes, not-for-profit organizations, or industry that work on the identification, synthesis, and evaluation of direct-acting antiviral or host-targeting agents that inhibit viral replication or pathogenesis. Furthermore, we also welcome the submission of mechanistic studies of new small organic molecules, metal complexes, and natural products, as well as studies on drug resistance, the in silico design of antiviral agents, and antiviral target validation.
Dr. Grigoris Zoidis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiviral drugs
- antiviral agents
- small organic molecules
- metal complexes
- natural products
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
